<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00478491</url>
  </required_header>
  <id_info>
    <org_study_id>2002-515</org_study_id>
    <secondary_id>NIH RO1 AG021155A</secondary_id>
    <nct_id>NCT00478491</nct_id>
  </id_info>
  <brief_title>fMRI of Vulnerable Brain Regions in Persons at Risk for Alzheimer's Disease</brief_title>
  <acronym>ALZ</acronym>
  <official_title>fMRI of Vulnerable Brain Regions in Persons at Risk for Alzheimer's Disease</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Wisconsin, Madison</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Institutes of Health (NIH)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
    <collaborator>
      <agency>National Institute on Aging (NIA)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Wisconsin, Madison</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to investigate the organization of memory and develop future
      methods for early detection of AD. Using functional magnetic resonance imaging (fMRI), we
      examine the responsiveness of the brain to memory tasks, specifically focusing on regions of
      the brain (the mesial temporal lobe and posterior cingulate) that are known to be involved in
      early stages of Alzheimer's disease (AD). Of interest are differences in brain activation
      between people with and without a family history of AD and other risk factors.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>January 2003</start_date>
  <completion_date type="Actual">July 2011</completion_date>
  <primary_completion_date type="Actual">June 2011</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <number_of_groups>4</number_of_groups>
  <enrollment type="Actual">390</enrollment>
  <condition>Magnetic Resonance Imaging</condition>
  <condition>Alzheimer's Disease</condition>
  <condition>Dementia</condition>
  <condition>Adult Children</condition>
  <condition>Risk</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <description>Persons with a parent with Alzheimer's disease</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <description>Persons whose parents survived to old age without memory problems</description>
  </arm_group>
  <arm_group>
    <arm_group_label>3</arm_group_label>
    <description>Persons with diagnosed mild cognitive impairment</description>
  </arm_group>
  <arm_group>
    <arm_group_label>4</arm_group_label>
    <description>Persons without memory problems</description>
  </arm_group>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      plasma and serum
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Persons with a parent with Alzheimer's disease will be recruited from the Wisconsin
        Registry for Alzheimer's Prevention (WRAP). Persons with MCI will be recruited from the UW
        clinics and satellite clinics. Controls for the above study groups will be recruited from
        the WRAP and the local community.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  MCI Group: Diagnosis of mild cognitive impairment

          -  AD Family History Group: Confirmed family history of Alzheimer's and concurrent
             enrollment in the Wisconsin Registry for Alzheimer's Prevention (WRAP)

          -  Control Groups: Cognitively healthy and both parents survived past age 70 with no
             memory problems

        Exclusion Criteria:

          -  Claustrophobia

          -  Metallic or electronic implants or devices that are not MRI-safe
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>40 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Sterling C Johnson, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Wisconsin/VA GRECC</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of Wisconsin - Wisconsin Comprehensive Memory Program</name>
      <address>
        <city>Madison</city>
        <state>Wisconsin</state>
        <zip>53792</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>http://www.brainmap.wisc.edu</url>
    <description>Website for the Sterling Johnson Imaging Lab</description>
  </link>
  <results_reference>
    <citation>Ries ML, Jabbar BM, Schmitz TW, Trivedi MA, Gleason CE, Carlsson CM, Rowley HA, Asthana S, Johnson SC. Anosognosia in mild cognitive impairment: Relationship to activation of cortical midline structures involved in self-appraisal. J Int Neuropsychol Soc. 2007 May;13(3):450-61.</citation>
    <PMID>17445294</PMID>
  </results_reference>
  <results_reference>
    <citation>Johnson SC, Schmitz TW, Trivedi MA, Ries ML, Torgerson BM, Carlsson CM, Asthana S, Hermann BP, Sager MA. The influence of Alzheimer disease family history and apolipoprotein E epsilon4 on mesial temporal lobe activation. J Neurosci. 2006 May 31;26(22):6069-76.</citation>
    <PMID>16738250</PMID>
  </results_reference>
  <results_reference>
    <citation>Trivedi MA, Schmitz TW, Ries ML, Torgerson BM, Sager MA, Hermann BP, Asthana S, Johnson SC. Reduced hippocampal activation during episodic encoding in middle-aged individuals at genetic risk of Alzheimer's disease: a cross-sectional study. BMC Med. 2006 Jan 13;4:1.</citation>
    <PMID>16412236</PMID>
  </results_reference>
  <results_reference>
    <citation>Ward MA, Carlsson CM, Trivedi MA, Sager MA, Johnson SC. The effect of body mass index on global brain volume in middle-aged adults: a cross sectional study. BMC Neurol. 2005 Dec 2;5:23.</citation>
    <PMID>16321166</PMID>
  </results_reference>
  <results_reference>
    <citation>Ries ML, Schmitz TW, Kawahara TN, Torgerson BM, Trivedi MA, Johnson SC. Task-dependent posterior cingulate activation in mild cognitive impairment. Neuroimage. 2006 Jan 15;29(2):485-92. Epub 2005 Aug 15.</citation>
    <PMID>16102979</PMID>
  </results_reference>
  <verification_date>October 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 22, 2007</study_first_submitted>
  <study_first_submitted_qc>May 22, 2007</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 24, 2007</study_first_posted>
  <last_update_submitted>October 25, 2016</last_update_submitted>
  <last_update_submitted_qc>October 25, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 27, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Alzheimer Disease</mesh_term>
    <mesh_term>Dementia</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

